by Every baby in England is intended to carry out a DNA screening to avoid fatal diseases and to receive a personalized health care as part of the 650 millions of pounds of the government.
Within a decade, each newborn will undergo the sequencing of the entire genome, which evaluates the risk of hundreds of diseases and is expected to be part of the government’s 10-year plan for the health service.
Wes Streeting’s health secretary told The Telegraph that the progress of genomics would enable people to “exceed” killer diseases and to receive “personalized” health care.
He said: “The revolution in medicine means that in the coming decade we can transform the NHS from a service that diagnoses and treats the disease that predicts and prevents it.
“Genomics offers us the opportunity to exceed the disease, so we are there instead of reacting to it.”
The street added: “With the power of this new technology, patients can receive personalized health care to prevent the disease before the symptoms begin, reducing pressure on NHS services and helping people to live a longer and healthier life.”
All new parents are now offered a blood spot test for their babies, usually when the child is five days old to check whether it has one of nine rare but serious conditions. The newborn heel is stung to collect a few drops of blood on a card that is sent to test.
Together with a stronger focus on prevention, the 10-year plan is expected to include the other “layers” of Streeting in the NHS, from hospitals to more focused care in the municipality and from analogous to digital services.
Last week, Chancellor Rachel Reeves announced that the government would increase the NHS financing by 29 billion GBP per year in the next three years.
A spokesman for the Ministry of Health and Social Affairs said: “Our 10-year health plan will be released shortly and will set details for a number of initiatives about the NHS recovery and make it fit for the future.”
In October, the NHS announced in England to check 100,000 newborns for more than 200 genetic diseases in a worldwide first scheme to strengthen early diagnosis and treatment.
